Methods and apparatus for treating glottic insufficiency

ABSTRACT

An implant system for treating glottic insufficiency includes an implant, which includes a balloon with a port connector or a catheter and a band comprising a proximate end attached to a portion of the balloon that translates away from the port connector or the catheter when the balloon is inflated through the port connector or the catheter.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a continuation under 35 U.S.C. § 120 of U.S.Nonprovisional application Ser. No. 15/310,107, filed Nov. 10, 2016,which is a U.S. National Stage filing under 35 U.S.C. § 371 ofInternational Application PCT/US2015/020633, filed Mar. 15, 2015, whichclaims the benefit of U.S. Provisional Application No. 62/048,816, filedSep. 11, 2014, and U.S. Provisional Application No. 62/065,457, filedOct. 17, 2014. The U.S. Nonprovisional Application, the InternationalApplication, and the U.S. Provisional Applications, including anyappendices or attachments thereof, are incorporated by reference hereinin their entirety.

BACKGROUND

Dysphagia associated with aspiration pneumonia often occurs in patientswith neurological disorders. The neurological disorders may be caused bystroke, brain surgery, head and/or spinal cord trauma, oropharyngealdisease, radiation therapy, cardiac/thoracic surgery, autoimmune orother degenerative neurologic diseases. The aspiration pneumonia may bemainly caused by glottic insufficiency, due to vocal fold paralysiswith/without swallowing dysfunction. Stroke patients with aspirationsymptoms may have a seven-time higher risk in developing aspirationpneumonia than other types of patients. For these stroke patients, evenafter recovery, there is still a relatively high incidence of dysphagiaassociated with aspiration pneumonia.

Conventional surgical techniques to treat dysphagia and glotticinsufficiency may include Type I Medialization Thyroplasty (MT)procedure and Arytenoid Adduction (AA) procedure. Type I MT procedure isthe main phonosurgical procedure performed in patients with glotticinsufficiency. The primary limitations of Type I MT procedure includethe inability to close a wide posterior glottal chink and restore thephysiological swallowing steps, like laryngeal elevation and vocal foldmovement. For patients with vocal cord paralysis and a significantposterior glottic gap after the Type I MT procedure, an AA procedure maybe performed subsequently to close the incompletely closed posteriorglottis. Still, one limitation of the AA procedure, associated with theposterior airway closure, is an increased frequency of postoperativeairway complaints after the AA procedure, due to postoperative tissueedema in the glottis area. Further, Type I MT and AA procedures may notbe suitable for patients having difficulty with prolonged periods ofsupine positioning or intolerable for long lasting surgical procedures.

Since the above two procedures either use implants or suture fixationtechnique, a common complaint from these procedures is the inability toprecisely adjust the implant or sutures intraoperatively andpostoperatively. Specifically, it is difficult to accurately performintraoperative adjustment of implant due to edematous swelling of vocaltract mucosa caused by these procedures. For example, carving an implantduring surgery may result in prolonged operation time and suboptimalshaping of the implant. Furthermore, these implants cannot bepostoperatively adjusted at all.

Providing an adjustable implant for the procedure would shorten theoperation time, and reduce the risk of postoperative airway compromise.The adjustable implant would be customized for each individual's needs,from which the patient could greatly benefit.

SUMMARY

In examples of the present disclosure, an implant system to treatglottic insufficiency includes an implant with a balloon and a band. Theballoon has a port connector, and the band has a proximate end attachedto a portion of the balloon that translates away from the port connectorwhen the balloon is inflated through the port connector.

In examples of the present disclosure, a method to treat glottisinsufficiency includes creating a window in a thyroid cartilage,inserting the implant through the window and into a paraglottic space,securing the band to a thyroarytenoid muscle complex, includingsurrounding connective tissue, and inflating the balloon to pull theband, which in turn pulls on the thyroarytenoid muscle complex, which inturn rotates an arytenoids cartilage to medialize and tighten a vocalcord.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1A illustrates various views of larynx anatomy.

FIG. 1B illustrates various symptoms of glottic insufficiency.

FIGS. 2A and 3 illustrate top and lateral views of an implant systemwith an implant in a paraglottic space to treat glottic insufficiencyand a mount to fix the implant to a thyroid cartilage in examples of thepresent disclosure.

FIGS. 2B and 4 illustrate a mechanism of the implant of FIGS. 2A and 3in examples of the present disclosure.

FIGS. 5A, 5B, and 5C illustrate methods of connecting the implant ofFIG. 2 with thyroarytenoid muscle in examples of the present disclosure.

FIG. 6 illustrates the mount of FIG. 2 with an outer fixture to fit intoa cartilage opening and a port to be placed into the outer fixture inexamples of the present disclosure.

FIG. 7 illustrates using a delivering device to inject a filler into theport of FIG. 6 in examples of the present disclosure.

FIGS. 8A and 8B illustrate a mount with an outer fixture and a fixtureplate to fit into a cartilage opening in examples of the presentdisclosure.

FIG. 9 illustrates the mount of FIGS. 8A and 8B fixing an implant in theparaglottic space in examples of the present disclosure.

FIG. 10 illustrates an implant including a flexible member and a mountintegrated with the flexible member in examples of the presentdisclosure.

FIG. 11 illustrates inflating an implant in examples of the presentdisclosure.

DETAILED DESCRIPTION

In the following detailed description, reference is made to theaccompanying drawings, which form a part hereof. In the drawings,similar symbols typically identify similar components, unless contextdictates otherwise. The illustrative embodiments described in thedetailed description, drawings, and claims are not meant to be limiting.Other embodiments may be utilized, and other changes may be made,without departing from the spirit or scope of the subject matterpresented here. It will be readily understood that the aspects of thepresent disclosure, as generally described herein, and illustrated inthe Figures, can be arranged, substituted, combined, and designed in awide variety of different configurations, all of which are explicitlycontemplated herein.

The present disclosure describes apparatuses and methods to treatdysphagia, glottic insufficiency (due to neuromuscular incoordination ordisordered interaction (cooperation) between the intrinsic muscles), andthe poor closure of larynx inlet (opening) (due to uncoordinated bendingof epiglottis and delayed or absence of laryngeal elevation). Thedisclosed treatments may improve the glottic closure, reduce theincidence of aspiration, and thus preventing the aspiration's sequelae,such as aspiration pneumonia. Furthermore, the disclosed treatments mayenable the postoperative adjustment of implants, and reduce the risk ofpostoperative airway compromise. As a result, the disclosed treatmentsmay shorten the operation time during the surgical procedures, andeffectively reduce/prevent aspiration pneumonia after the surgicalprocedures.

In examples of the present disclosure, an implant system mimics thecontraction of the thyroarytenoid muscle to close the glottis byrotating the arytenoid cartilage. The contraction is adjustable bychanging the size of an implant by changing the amount of filler in theimplant. The present disclosure may replace both type I thyroplasty andAA surgical techniques because it offers shortened surgical time andpostoperatively adjustable implant size.

FIG. 1A illustrates various views of larynx anatomy.

Drawing 110 shows the anatomy of a patient's larynx in an anterior view,with the outer side 111 of the thyroid cartilage exposed. Drawing 120shows the same patient's larynx in a posterior view, with the inner side121 of the thyroid cartilage exposed. Drawing 120 further shows thepatient's vocal ligament 122, which are enclosed within the patient'svocal folds (not shown in the drawing 120). Drawing 130 shows the samepatient's laryngeal cartilages (including a cross-sectional view 131 ofthe thyroid cartilage) in an angled lateral view. In examples of thepresent disclosure, the space surrounded by the laryngeal cartilages, aswell as the tissues and organs connected to these cartilages, may bedeemed a “paraglottic space.” In other words, the paraglottic space maybe a space bounded by the thyroid cartilage and the various surroundingmembranes.

FIG. 1B illustrates various symptoms of glottic insufficiency.

Drawing 140 illustrates an example healthy vocal cord having twolateralized vocal folds 141 and 142. During normal breathing, swallowingor speaking, the two vocal folds 141 and 142 open and close in unison.Before a person swallows food, the food or drink is first crushed and/ormixed into a pasty mass known as a bolus. During swallowing, theperson's extrinsic and intrinsic muscles cooperate to prevent food ordrink from entering the glottis. For example, the person's extrinsicmuscles elevate the larynx and bend the epiglottis over the entrance tothe glottis so that the bolus can glide across the epiglottis ratherthan falling into the larynx. While this movement is under way, theperson's intrinsic muscles close the glottis. Should any food particlesor liquids touch the surface of the vestibular or vocal folds 141 and142, a cough reflex may be triggered to prevent the material fromentering the glottis.

Drawing 150 illustrates an example unhealthy vocal cord having aparalyzed vocal fold 151 unable to move to a fullylateralized/medialized position. In other words, the paralyzed vocalfold 151 cannot be opened and closed in unison with the other vocalfold, leaving an opening or gap in the glottis. Thus, during swallowing,the bolus may inadvertently slip into the larynx and subsequently intothe trachea, bronchus, and lungs, which may lead to infection andpneumonia. Further, as shown in drawing 160, for some of the strokepatients, due to impaired neurological stimulus, the trigger ofepiglottis bending, the vocal closure 161, and/or the laryngealelevation 162 are delayed or absent, leading to incoordination of theirextrinsic and intrinsic muscle movements. As a result, the patient mayhave difficulty swallowing and choking as well.

To treat a patient's glottic insufficiency and/or swallowing difficulty,drawing 170 shows that a surgeon or a medical machinery utilizes asurgical device to create a cartilage opening 172 in the patient'sthyroid cartilage 171. The surgical device may perform certain functionssuch as drilling, shaping, space expansion (e.g., “dissection”), andinstrument/implant delivery. Afterwards, the surgeon or the medicalmachinery places an implant system through the cartilage opening 172into the paraglottic space behind the patient's thyroid cartilage 171.The implant system is configured to facilitate epiglottis bending orperform laryngeal elevation so that a paralyzed larynx may be betterclosed during bolus swallowing.

FIG. 2A illustrates a top view of an implant system 200 positioned in aparaglottic space for treating glottic insufficiency in examples of thepresent disclosure. The top of the figure is the anterior aspect oflarynx and the bottom of the figure is the posterior aspect of larynx.The implant system 200 includes an implant 201. The implant 201 includesat least one main body 202 and at least one band or strip 203. Theimplant 201 is inserted through an opening or window 211 in the thyroidcartilage 205 into the paraglottic space. The main body 202 has a shapethat fits into the paraglottic space between the thyroid cartilage 205,adipose tissue, and the thyroarytenoid muscle complex 207. The main body202 may be a flexible or expandable member. Inflation of the flexiblemember 202 may push thyroarytenoid muscle complex 207 and a vocal fold206 medially and may cause rotation of the arytenoid cartilage 208,which may benefit the glottic closure. The flexible member 202 may be aballoon or another similar device that may expand and contract. Forexample, the flexible member 202 is substantially a triangular blockshaped balloon with a first lateral surface 216 corresponding to thearytenoid cartilage 208, a second lateral surface 217 corresponding tothe vocal cord 206, and a third lateral surface 218 corresponding to thethyroid cartilage 205.

The implant system 200 includes a mount 210 secured to the opening 211in the thyroid cartilage 205. The mount 210 fixes the flexible member202 to the thyroid cartilage 205.

The implant system 200 includes a port 204. The port 204 is a deviceconfigured to maintain and deliver filler. The filler may be added to orremoved from the flexible member 202 intraoperatively orpostoperatively. In some example, the port 204 is part of the mount 210that fixes the flexible member 202 to the thyroid cartilage 205. Theport 204 fits in an outer fixture 209 of the mount 210. The port 204 isconnected to the flexible member 202 via a port connector 212 on thelateral side 218 of the flexible members 202 facing the thyroidcartilage 205. Further device fixation and stabilization can be providedwhen the outer fixture 209 or the port 204 is nailed or screwed to thethyroid cartilage 205.

In other examples, the port 204 is separate from the mount 210. The port204 is located away from the mount 210, such as in a lower area of theneck. The port 204 is connected to the flexible member 202 via acatheter on the lateral side 218 of the flexible member 202.

The flexible member 202 and band 203 are made of biocompatiblematerials, such as silicon or biodegradable materials. The flexiblemember 202 may be composed with a layer of varied stiffness and/orthickness in order to provide a designated expansion direction.

The band 203 may be rigid, semi-rigid, or soft. It may be made byintegrating meshed textile into biocompatible materials. Stiffness ofthis layer can be changed by the mesh density of the integratedtextiles. The band 203 has a proximate end 214 attached to a portion ofthe flexible member 202 that translates away from the port connector 212when the flexible member 202 is inflated through the port connector 212.The portion may be part of the superior, inferior, lateral, or medialsurface of the expandable member 202.

FIG. 2B shows therapeutic effects after the implant system 200 isplanted into the paraglottic space. The shape and size of the flexiblemember 202 may be adjustable by adding/removing filler to/from theflexible member 202 via the port 204 during operation(intraoperatively). After operation (postoperatively), when acomplication occurs, the flexible member 202 may be readjusted to handleairway compromise. Thus, the implant system 200 may effectivelymedialize and tighten the paralyzed vocal fold 206. As a result, therisk of aspiration pneumonia can be significantly reduced. The implantsystem 200 may be similarly adjusted and readjusted eitherintraoperatively or postoperatively. Thus, the implant system 200 mayallow faster operation time, which in turn would increase patients'acceptance of the procedure.

FIG. 3 illustrates a lateral view of the implant system 201 positionedat the paraglottic space for treating glottic insufficiency in examplesof the present disclosure. The right-hand side of the figure is theanterior aspect of the larynx and the left-hand side of the figure isthe posterior aspect of the larynx. The flexible member 202 is deployedinto the space between the thyroid cartilage 205, adipose tissue, andthe thyroarytenoid muscle complex 207. A portion of the flexible member202 indirectly contacts the arytenoid cartilage 208 through muscles andconnective tissues therebetween. The proximate end 214 of the band 203may be integrated into or otherwise attached to the flexible member 202at its lateral, superior, and/or inferior surfaces while a distal end215 is attached or otherwise secured to the posterior portion of thethyroarytenoid muscle complex 207 by, e.g., sutures, clips, or hooks.

Expansion of the flexible member 202 may contribute to both medialmovement of the paralyzed vocal fold 206 (FIG. 2) and rotation of thearytenoid cartilage 208. The flexible member 202 may also extend itsposition vertically, thus reaching the supraglottic space, resulting inelevation of larynx and acceleration of epiglottis closure duringswallowing. The flexible member 202 may be extended into thepara-epiglottic space, to enhance closure of the paralyzed vocal fold206 to a nearly complete or fully medialized position.

FIGS. 2B and 4 illustrate a mechanism of implant 201 for bringing theparalyzed vocal fold 206 (FIG. 2) to a nearly complete or fullymedialized position in examples of the present disclosure. The left-handside of the figure demonstrates the implant 201 before inflation of theflexible member 202, and the right-hand side of the figure demonstratesthe implant 201 after inflation of the flexible member 202. Inflation ofthe flexible member 202 causes the band 203 to move in a designateddirection 402. The movement of the band 203 creates a traction force onthe thyroarytenoid muscle complex 207. Traction of the thytoarytenoidmuscle complex 207 leads to rotation of the arytenoid cartilage 208.Rotation of the arytenoid cartilage 208 positions the paralyzed vocalfold 206 (FIG. 2) to a nearly complete or fully medialized position.

FIGS. 5A, 5B, and 5C illustrate methods of connecting the implant 201with the thyroarytenoid muscle complex 207 in examples of the presentdisclosure. One or multiple bands 203 are attached to the flexiblemember 202. In FIG. 5A, the band 203 is wrapped around thethyroarytenoid muscle complex 207 with the distal end 215 of the band203 attached to the flexible member 202. For example, the proximate end214 of the band 203 is attached to the superior, inferior, lateral, ormedial surface of the flexible member 202 while the distal end 215 ofthe band 203 is attached to the inferior, superior, lateral, or medialsurface of the flexible member 202. In FIG. 5B, the band 203 is attachedto the thyroarytenoid muscle complex 207 with sutures, clips, or hooks.For example, the proximate end 214 of the band 203 is attached to thesuperior, inferior, lateral, or medial surface of the flexible member202 while the distal end 215 of the band 203 is attached to thethyroarytenoid muscle complex 207 with a suture 503. In FIG. 5C, theband 203 is wrapped around the thyroarytenoid muscle complex 207 andattached to the port connector 212 of the flexible member 202. Forexample, the proximate end 214 of the band 203 is attached to thesuperior, inferior, lateral, or medial surface of the flexible member202 while a looped distal end 215 is hooked onto the port connector 212of the flexible member 202.

Movement of the band(s) 203, after being interconnected to thethyroarytenoid muscle complex 207, causes traction force to thethyroarytenoid muscle complex 207, which causes the arytenoid cartilage208 (FIG. 2) to rotate. This connection may also provide fixation of theimplant preventing any relative movement in the paraglottic space.

FIG. 6 illustrates the mount 210 with the outer fixture 209 to fit intothe cartilage opening 211 and the port 204 to be placed into the outerfixture 209 in examples of the present disclosure. A surgeon or amedical machinery uses a surgical device to create the cartilage opening211 on the patient's thyroid cartilage 205. The cartilage opening 211may have a circular or rectangular shape. The surgical device may be,without limitations, a cutter, a drill, a saw, or a punch (e.g., aKerrison punch). The surgical tool may be operated manually,electrically, mechanically, or magnetically.

After the surgeon or the medical machinery has delivered the implantinto the patient's paraglottic space, the outer fixture 209 is placedinto the cartilage opening 211. The outer fixture 209 may be made byusing materials such as elastomer, silicone, polymer, syntheticmaterial, ENT synthetic, porous polyethylene, ENT synthetic-PIFE,silicon elastomer, polyethylene, and polyurethane. The outer fixture 209may be flexible so that it can be squeezed into the cartilage opening211. The outer fixture 209 may have flanges 602 that cover the cartilageopening 211. The flanges 602 may prevent enlargement or progression ofthe crack or damage at the edge of the cartilage opening 211 during thesurgery. The outer fixture 209 may have a rough outer side surface. As aresult, when the outer fixture 209 is placed into the cartilage opening211, the rough outer side surface may generate sufficient frictions tostabilize the outer fixture 209 from slipping or rotating in thecartilage opening 211. The outer fixture 209 may be further secured bynails or screws to the thyroid cartilage 205. Furthermore the outerfixture 209 can also function as an insertion plate, thus preventing theflexible member 202 from being damaged by cartilage window rough surfaceduring implantation.

The port 204 is a device configured to maintain and deliver filler,therefore, filler may be added to or removed from the implantintraoperatively or postoperatively. The port 204 includes least onechamber with a septum 604 and an implant connector 606 that mates withthe port connector 212 of the flexible member 202 (FIG. 2) foradding/extracting fillers to/from the flexible member 202. For example,the implant connector 606 of the port 204 has internal threads thatscrew onto external threads on the port connector 212 of the expandablemember 202.

FIG. 7 illustrates diagram of using an injector 702 to deliver fillerinto the port 204 in examples of the present disclosure. The port 204acts as a delivery mechanism to add filler to, or extract filler from,the expandable member 202 (FIG. 2). The port 204 may also act as a valveto maintain the amount of filler in the flexible member 202. Theinjector 702 may be used to add or extract filler via the septum 604.Once the injector 702 completes the adding or extracting actions, theseptum 604 may automatically seal itself off, thereby maintaining theamount of filler in the semi-closed delivery system.

FIGS. 8A and 8B illustrate a mount 800 to fit into a cartilage opening802 to fix an implant, such as the implant 201 (FIG. 2) or 901 (FIG. 9),in examples of the present disclosure. In FIG. 8A, a surgeon or amedical machinery uses a surgical device to create the cartilage opening802 on the patient's thyroid cartilage 205. The cartilage opening 802may have a rectangular or circular shape. The surgical device may be,without limitations, a cutter, a drill, a saw, or a punch (e.g., aKerrison punch). The surgical tool may be operated manually,electrically, mechanically, or magnetically.

In FIG. 8B, after the surgeon or the medical machinery has delivered theimplant into a patient's paraglottic space, the mount 800 with an outerfixture 804 and a fixation plate 803 are placed into the cartilageopening 802. The outer fixture 804 may be made by using materials suchas elastomer, silicone, polymer, synthetic material, ENT synthetic,porous polyethylene, ENT synthetic-PIFE, silicon elastomer,polyethylene, and polyurethane. The outer fixture 804 may be flexible,so that it can be squeezed into the cartilage opening. The outer fixture804 may have flanges that cover the cartilage opening 802. The flangesmay be used to prevent enlargement or progression of the crack or damageat the edge of the cartilage opening 802 during the surgery and alsoprevent the implant from being damaged by the rough or sharp edges onthe cartilage window during implantation.

After the outer fixture 804 is placed into the cartilage opening 802, afixation plate 803 may be placed in the outer fixture 804. The fixationplate 803 may be made by using materials such as elastomer, silicone,polymer, synthetic material, ENT synthetic, porous polyethylene, ENTsynthetic-PIFE, silicon elastomer, polyethylene, and polyurethane. Thefixation plate 803 may be flexible so that it can be squeezed into theouter fixture 804. The fixation plate 803 may include a catheter/portopening 806 and a band opening 805. A catheter from the implant or animplant connector of a port (e.g., the implant connector 606 of the port204) may go through the catheter/port opening 806 while the band 203 maygo through the band opening 805 to be fixed with the fixation plate 803.

FIG. 9 illustrates a bottom view of the mount 800 to fix an implant 901in the paraglottic space in examples of the present disclosure. Theimplant 901 is similar to implant 201 but the expandable member 202includes a catheter 912 instead of the port connector 212. The outerfixture 804 includes flanges 902 and 904 that form outer groove 906 andinner groove 908. The outer groove 906 is used to fix the outer fixture804 inside the cartilage opening 802 of the thyroid cartilage 205. Thefixation plate 803 is fixed at the inner groove 908 of the outer fixture804. The catheter 912 on the lateral side of the flexible member 202extends through the catheter/port opening 806 to connect with theimplant connector 606 of the port 204. In other examples where theimplant 201 is used with the mount 800, the port connector 212 on thelateral side of the flexible member 202 extends through thecatheter/port opening 806 to connect with the implant connector 606 ofthe port 204. The band 203 is wrapped around the thyroarytenoid musclecomplex 207, and the distal end 215 of the band 203 goes through theband opening 805 of the fixation plate 803 and becomes fixed using afixation needle or pin 906.

FIG. 10 illustrates an implant 1001 including an expandable member 1002and a mount 1004 integrated with the expandable member 1002 in examplesof the present disclosure. Flexile member 1002 is a variation of theexpandable member 202 where the band 203 has been omitted for clarity'ssake. The integrated mount 1004 is a flanged tubular portion thatextends from a lateral side 1006 of the expandable member 1002. Theintegrated mount 1004 defines a channel 1008 to be connected to a portconnector or catheter to be connected to a port. The portion of theintegrated mount 1004 between a flange 1010 at the end of the integratedmount 1004 and the lateral side 1006 of the expandable member 1002defines a groove that fixes the implant 1000 in the opening 211 of thethyroid cartilage 205. The integrated mount 1004 may be made by usingmaterials such as elastomer, silicone, polymer, synthetic material, ENTsynthetic, porous polyethylene, ENT synthetic-PIFE, silicon elastomer,polyethylene, and polyurethane. The integrated mount 1004 may beflexible so that it can be squeezed into the opening 211 of the thyroidcartilage 205.

FIG. 11 illustrates inflating an implant with an expandable member 1102in examples of the present disclosure. The expandable member 1102 is avariation of the expandable member 202 where the band 203 has beenomitted for clarity's sake. FIG. 11A shows a top view of the expandablemember 1102, FIG. 11B shows a front view of the expandable member 1102before inflation, and FIG. 11C shows a front view of the expandablemember 1102 after inflation. Boundary of the expandable member may havedifferent properties to control the inflation of the expandable memberin a desired direction, volume, pressure, and/or force. These propertiesmay include but not limited to the thickness, density, stiffness, andelasticity of the boundary of the expandable member 1102. For example,as shown in FIG. 11B, the expandable member 1102 is thicker at medialand lateral sides, and thinner at top and bottom sides. The expandablemember 1102 is narrower at the middle section. As the expandable member1102 is inflated, FIG. 11C shows the expandable member 1102 expandslaterally greater than vertically and longitudinally.

Referring back to FIGS. 2A and 2B, in some examples of the presentdisclosure, the implant 201 has a main body 202 that is a mechanical,electrical, magnetic, or piezoelectric actuator. The actuator 202 canelongate to pull on the band 203, which in turn pulls on thethyroarytenoid muscle complex 207, which in turn rotates the arytenoidscartilage 208 to medialize and tighten the vocal cord 206.

In other examples of the present disclosure, the implant 201 has a mainbody 202 of a fixed size. The implant 201 is selected from implantshaving main bodies of different sizes to match a patient's theparaglottic space. Alternatively material is removed from the main body202 to match the patient's paraglottic space. The length of band 203between its attachment points determines the pull on the thyroarytenoidmuscle complex 207, which in turn determines the rotation of thearytenoids cartilage 208 to medialize and tighten the vocal cord 206.

The actuator 202 or the fixed size main body 202 has a mount connector212 instead of the port connector 212 to be fixed to the mount 210. Themount 210 is a closed piece with the implant connector 606 but withoutthe port 204, or the port 204 is replaced with an inner fixture 204inside the outer fixture 209. Alternatively the actuator 202 is fixed tothe mount 800 (FIG. 8B) with an implant connector 806 instead of animplant connector/port opening 806.

Thus, apparatuses and methods for treating glottic insufficiency havebeen disclosed. The various embodiments described herein may employ adevice or an apparatus for performing these methods. The apparatus maybe specially constructed for specific required purposes, or it may be ageneral purpose computer selectively activated or configured by acomputer program stored in the computer. In particular, various generalpurpose machines may be used with computer programs written inaccordance with the teachings herein, or it may be more convenient toconstruct a more specialized apparatus to perform the requiredoperations. The various embodiments described herein may be practicedwith other computer system configurations including hand-held devices,microprocessor systems, microprocessor-based or programmable consumerelectronics, minicomputers, mainframe computers, and the like.

Although one or more embodiments of the present disclosure have beendescribed in some detail for clarity of understanding, it will beapparent that certain changes and modifications may be made within thescope of the claims. Accordingly, the described embodiments are to beconsidered as illustrative and not restrictive, and the scope of theclaims is not to be limited to details given herein, but may be modifiedwithin the scope and equivalents of the claims. In the claims, elementsand/or steps do not imply any particular order of operation, unlessexplicitly stated in the claims.

Plural instances may be provided for components, operations orstructures described herein as a single instance. Finally, boundariesbetween various components, operations and data stores are somewhatarbitrary, and particular operations are illustrated in the context ofspecific illustrative configurations. Other allocations of functionalityare envisioned and may fall within the scope of the disclosure(s). Ingeneral, structures and functionality presented as separate componentsin exemplary configurations may be implemented as a combined structureor component. Similarly, structures and functionality presented as asingle component may be implemented as separate components. These andother variations, modifications, additions, and improvements may fallwithin the scope of the appended claims(s).

What is claimed is:
 1. An implant system for treating glotticinsufficiency, comprising: an implant, comprising: a balloon with a portconnector or a catheter; and a band comprising a proximate end attachedto a portion of the balloon, wherein the portion of the balloontranslates away from the port connector or the catheter when the balloonis inflated through the port connector or the catheter, and the ballooncomprises medial and lateral sides that are thicker than top and bottomsides so the balloon expands laterally greater than vertically andlongitudinally when the balloon is inflated.
 2. The implant system ofclaim 1, wherein the balloon comprises a substantially triangular blockshaped balloon.
 3. The implant system of claim 2, wherein thesubstantially triangular block shaped balloon has a first lateralsurface corresponding to an arytenoid cartilage, a second lateralsurface corresponding to a vocal cord, and a third lateral surfacecorresponding to a thyroid cartilage.
 4. The implant system of claim 3,wherein the port connector or the catheter protrudes from the thirdlateral surface.
 5. The implant system of claim 4, wherein the proximateend of the band is attached to a superior surface, a lateral surface, aninferior surface, or a medial surface of the balloon.
 6. The implantsystem of claim 5, further comprising: a mount, comprising: a fixturefit to a window opened in the thyroid cartilage; and a port in thefixture, the port comprising an implant connector capable of beingsecured to the port connector.
 7. The implant system of claim 6, whereinthe band comprises a looped distal end.
 8. The implant system of claim6, wherein the fixture comprises flanges.
 9. The implant system of claim6, wherein the port connector and the implant connector comprise threadsto engage each other.
 10. The implant system of claim 6, wherein theballoon comprises silicon and the band comprises a meshed textileintegrated into a biocompatible material.
 11. The implant system ofclaim 1, further comprising: a mount, comprising: an outer fixture fitto a window opened in the thyroid cartilage; and a fixation plate in theouter fixture, the fixation plate defining an opening to receive theport connector or the catheter.
 12. The implant system of claim 11,wherein the fixation plate further defines another opening to receive adistal end of the band.
 13. The implant system of claim 1, wherein theimplant further comprises a mount integrated with the balloon to fix theimplant to a window opened in the thyroid cartilage.